M. Perricone

发表

Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health.

J. Weinstein, E. Petricoin, T. Godfrey, 2005, Journal of immunotherapy.

Enhanced Efficacy of Melanoma Vaccines in the Absence of B Lymphocytes

J. Kaplan, J. S. St. George, B. Roberts, 2004, Journal of immunotherapy.

Analysis of cellular immune responses in the peripheral blood of mice using real-time RT-PCR.

M. Perricone, Karen A. Smith, K. A. Claussen, 2002, Journal of immunological methods.

Double-stranded RNA regulation of DNA synthesis in fibroblasts.

D. Hyde, M. Perricone, S. Giri, 1992, Experimental cell research.

Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens.

J. Kaplan, K. Smith, B. Roberts, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients

M. Perricone, S. Richards, Yuanxin Xu, 2008, Journal of Translational Medicine.

Effects of dibutyrylcyclic adenosine monophosphate on bleomycin‐induced lung toxicity in hamsters

Qingjian Wang, D. Hyde, C. O’Neill, 1992, Journal of applied toxicology : JAT.

Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.

J. Morris, J. Marshall, J. Zabner, 1997, The Journal of clinical investigation.

A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis.

J. Clancy, J. Morris, Z. Bebők, 2001, Human gene therapy.

Development of an in vivo antibody-mediated killing (IVAK) model, a flow cytometric method to rapidly evaluate therapeutic antibodies.

J. Kaplan, M. Perricone, Karen A. Smith, 2008, Journal of immunological methods.

E4ORF3 Requirement for Achieving Long-Term Transgene Expression from the Cytomegalovirus Promoter in Adenovirus Vectors

J. Zabner, J. S. St. George, M. Perricone, 1999, Journal of Virology.

Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium.

J. Morris, K. Pavelka, Alan E. Smith, 2001, Human gene therapy.

Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells.

J. Kaplan, J. S. St. George, K. Smith, 2000, Human gene therapy.

Preclinical safety and biodistribution of adenovirus-based cancer vaccines after intradermal delivery.

J. S. St. George, B. Roberts, M. Perricone, 2006, Human gene therapy.

The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.

G. V. Vande Woude, B. Teicher, H. Yoshida, 2008, International journal of oncology.

Immunosuppressive activity of a novel peptide analog of alpha-melanocyte stimulating hormone (α-MSH) in experimental autoimmune uveitis

J. Kaplan, M. Perricone, John M. Williams, 2011, Journal of Neuroimmunology.

In Vivo Characterization of Rabbit Anti-Mouse Thymocyte Globulin: A Surrogate for Rabbit Anti-Human Thymocyte Globulin

M. Ruzek, M. Perricone, R. Garman, 2009, Transplantation.

Ultrastructure of pericytes in early stages of histamine‐induced inflammation

M. Perricone, D. Sims, A. Donald, 1990, Journal of morphology.

A retro‐inverso α‐melanocyte stimulating hormone analog with MC1R‐binding selectivity

W. Chuang, M. Perricone, T. Weeden, 2011, Journal of peptide science : an official publication of the European Peptide Society.

Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.

J. S. St. George, H. Dorkin, M. Perricone, 2001, Human gene therapy.